Display options
Cite
Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017;6:8doi: 10.1186/s40164-017-0068-3.
Mo, L., & Bao, G. C. (2017). Acquired factor VIII deficiency: two case reports and a review of literature. Experimental hematology & oncology, 68. https://doi.org/10.1186/s40164-017-0068-3
Mo, Lan, and Bao, George C. "Acquired factor VIII deficiency: two case reports and a review of literature." Experimental hematology & oncology vol. 6 (2017): 8. doi: https://doi.org/10.1186/s40164-017-0068-3
Mo L, Bao GC. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017 Mar 24;6:8. doi: 10.1186/s40164-017-0068-3. eCollection 2017. PMID: 28352491; PMCID: PMC5366150.
Copy Download .nbib Format: NLM
Share it on

Exp Hematol Oncol. 2017 Mar 24;6:8. doi: 10.1186/s40164-017-0068-3. eCollection 2017.

Acquired factor VIII deficiency: two case reports and a review of literature.

Experimental hematology & oncology

Lan Mo, George C Bao

Affiliations

  1. Weill Cornell Medicine, New York-Presbyterian Lower Manhattan Hospital, 170 William Street, New York, NY 10038 USA.

PMID: 28352491 PMCID: PMC5366150 DOI: 10.1186/s40164-017-0068-3

Abstract

BACKGROUND: Acquired factor VIII (FVIII) deficiency, or acquired hemophilia A (AHA), is a rare autoimmune disorder involving antibody-mediated depletion of coagulation FVIII, leading to severe, life-threatening bleeding. The condition is often associated with other autoimmune disorders, and its treatment involves replacement of FVIII and various modes of immunosuppression. Recently, a few noteworthy therapeutic advances have been made. We present two cases of severe AHA in Chinese women. One of these women developed this disorder in the setting of possible parvovirus B19 infection, which has not yet been reported in association with AHA. Other notable features of her case included paradoxical venous thrombosis and possible association with Sjogren's syndrome and myositis. The other woman failed to respond to usual first-line therapies despite exhibiting a less severe clinical course, illustrating the varied but potentially stubborn behavior of this disorder.

CASE 1: An 87-year-old woman presented with diffuse ecchymoses, melena, vaginal bleeding. Labs showed hemoglobin (Hgb) nadir of 5.7 mg/dL, elevated partial thromboplastin time (PTT), FVIII level <1%, mixing study consistent with an inhibitor, elevated anti-Sjogren's-Syndrome-related antigen A antibody, elevated creatinine kinase, and elevated parvovirus IgM and IgG. Imaging of her arm showed diffuse myositis and deep venous thrombosis. After intravenous and oral steroids, her FVIII levels normalized, and her symptoms subsided.

CASE 2: A 59-year-old woman presented with recurrent ecchymoses and hematomas in her extremities. Labs showed Hgb of 11.7 mg/dL, elevated PTT, FVIII level of 3%, and mixing study consistent with an inhibitor. Despite receiving a long course of steroids, several courses of IVIG, and a few courses of Rituximab, her FVIII level remained critically low.

CONCLUSION: The rarity of AHA limits our understanding of this disease and the ability to perform trials to discover optimal therapies. We hope that these case reports and discussion will shed further light on the varied clinical manifestations and natural histories of this disorder to guide better recognition and treatment of AHA.

Keywords: Acquired factor VIII deficiency; Acquired hemophilia A; Glucocorticoids; Immunosuppression; Intravenous Immunoglobulin; Myositis; Parvovirus B19; Rituximab

References

  1. Thromb Haemost. 1981 Jun 30;45(3):200-3 - PubMed
  2. Adv Ther. 2009 Jan;26(1):68-88 - PubMed
  3. Br J Haematol. 2010 Jan;148(2):183-94 - PubMed
  4. Br J Haematol. 2012 Jan;156(1):3-12 - PubMed
  5. Blood Transfus. 2016 Jul 25;:1-4 - PubMed
  6. Am J Case Rep. 2016 Apr 04;17 :214-8 - PubMed
  7. Arthritis Care Res (Hoboken). 2010 Jul;62(7):1047-50 - PubMed
  8. Haematologica. 2000 Oct;85(10 Suppl):64-8 - PubMed
  9. Clin Appl Thromb Hemost. 2002 Oct;8(4):375-9 - PubMed
  10. Haemophilia. 2015 Aug 17;:null - PubMed
  11. Blood. 2010 Jul 15;116(2):270-9 - PubMed
  12. Arch Intern Med. 1987 Jun;147(6):1077-81 - PubMed
  13. Am J Hematol. 2005 Sep;80(1):55-63 - PubMed
  14. Acta Haematol. 2008;119(1):8-11 - PubMed
  15. Blood. 2005 Mar 15;105(6):2287-93 - PubMed
  16. Blood. 2007 Mar 1;109 (5):1870-7 - PubMed
  17. Clin Appl Thromb Hemost. 2015 Jan;21(1):35-40 - PubMed
  18. Ann Pharmacother. 2001 Apr;35(4):501-4 - PubMed
  19. Blood. 2012 Jul 5;120(1):39-46 - PubMed
  20. J Blood Med. 2015 Sep 03;6:245-55 - PubMed
  21. Haemophilia. 2010 Jul 1;16(4):632-9 - PubMed
  22. N Engl J Med. 2016 May 26;374(21):2044-53 - PubMed
  23. J Blood Med. 2015 May 08;6:143-50 - PubMed
  24. Arch Dermatol. 2004 Jun;140(6):723-7 - PubMed
  25. Case Rep Rheumatol. 2012;2012:250537 - PubMed
  26. Haemophilia. 2014 May;20(3):e205-10 - PubMed
  27. J Formos Med Assoc. 2015 Apr;114(4):321-7 - PubMed
  28. Haemophilia. 2016 Jul;22 Suppl 5:36-41 - PubMed
  29. Hematology Am Soc Hematol Educ Program. 2006;:432-7 - PubMed
  30. Br J Haematol. 2003 Apr;121(1):21-35 - PubMed
  31. Drugs. 2005;65(9):1239-82 - PubMed
  32. Rheumatology (Oxford). 2003 Feb;42(2):349-52 - PubMed
  33. Blood. 2012 Jul 5;120(1):47-55 - PubMed
  34. J Thromb Haemost. 2015 Jan;13(1):72-81 - PubMed
  35. J Thromb Thrombolysis. 2006 Jun;21(3):279-84 - PubMed
  36. J Clin Virol. 2015 Nov;72 :69-74 - PubMed

Publication Types